Fibroblast Specific Inhibition of LOXL2 and TGFbeta1 Signaling in Patients With Pulmonary Fibrosis.
Summary
- Eligibility
- for people ages 40-70 (full criteria)
- Healthy Volunteers
- healthy people welcome
- Location
- at San Francisco, California
- Dates
- study startedestimated completion
- Principal Investigator
- by Hal A Chapman
Description
Summary
Details
Keywords
Eligibility
Location
Lead Scientist at UCSF
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT03928847
- Phase
- Phase 1
- Study Type
- Interventional
- Last Updated